United States · Biotechnology Research startup
United States · MyoKardia
MyoKardia is a clinical-stage biopharmaceutical company that develops targeted therapies for the treatment of rare cardiovascular diseases.
Funding reportedLast round: Post ipo equity
What company datasets say MyoKardia raised
Funding, as reported
Reported in all$98Min dollars
Rounds5
Last roundPost ipo equity
Last round dateAug 2017
Investors listed7
Founders and team
From the SEC filings it signed: 1 on the team.
- Tassos Anastasios GianakakosExecutive Officer, Directori
On the board, as filediCharles HomcyKatherine BowdishKevin StarrMark Perry
Biotechnology Research in United States
Startups like it
Apeel SciencesGoleta · founded 2012
Insilico MedicineBoston · founded 2014
Tidal VisionBellingham · founded 2015
SELLAS Life Sciences Group, Inc.New York · founded 2012
Artax Biopharma IncCambridge · founded 2013
Thrive Bioscience, Inc.Beverly · founded 2014
HistoWizBrooklyn · founded 2012
StemoniXMaple Grove · founded 2014
Is this your company?
Add your raise, your deck and your story, and put MyoKardia in front of investors. Or tell us what we have wrong.